These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36960735)

  • 1. Effect of the Diabetic Nephropathy Aggravation Prevention Program on medical visit behavior in individuals under the municipal national health insurance.
    Ikeda A; Fujii M; Ohno Y; Godai K; Li Y; Nakamura Y; Yabe D; Tsushita K; Kashihara N; Kamide K; Kabayama M
    J Diabetes Investig; 2023 Jun; 14(6):782-791. PubMed ID: 36960735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does disease management for diabetic nephropathy reduce medical expenditure? Evidence from a three-period difference-in-differences analysis.
    Kawaguchi H; Moriyama M; Hashimoto H
    BMC Health Serv Res; 2020 May; 20(1):403. PubMed ID: 32393380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effectiveness of a disease management program to prevent diabetic nephropathy: a propensity score matching analysis using administrative data in Japan.
    Watanabe H; Anezaki H; Kazawa K; Tamaki Y; Hashimoto H; Moriyama M
    BMC Endocr Disord; 2022 May; 22(1):135. PubMed ID: 35596152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial.
    McMullan CJ; Lambers Heerspink HJ; Parving HH; Dwyer JP; Forman JP; de Zeeuw D
    Am J Kidney Dis; 2014 Nov; 64(5):714-22. PubMed ID: 25064674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research note changes in the number of outpatient visits in Japan during the COVID-19 pandemic.
    Machida M; Nishioka Y; Noda T; Imamura T
    BMC Res Notes; 2023 May; 16(1):70. PubMed ID: 37143139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of tooth loss among patients with diabetes mellitus using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
    Suzuki S; Noda T; Nishioka Y; Imamura T; Kamijo H; Sugihara N
    Int Dent J; 2020 Aug; 70(4):308-315. PubMed ID: 32103503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Japan Diabetic Nephropathy Cohort Study: study design, methods, and implementation.
    Furuichi K; Shimizu M; Toyama T; Koya D; Koshino Y; Abe H; Mori K; Satoh H; Imanishi M; Iwano M; Yamauchi H; Kusano E; Fujimoto S; Suzuki Y; Okuda S; Kitagawa K; Iwata Y; Kaneko S; Nishi S; Yokoyama H; Ueda Y; Haneda M; Makino H; Wada T;
    Clin Exp Nephrol; 2013 Dec; 17(6):819-26. PubMed ID: 23446518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a simulation model and evaluation of the effect of potential interventions on the incidence of diabetes and initiation of dialysis due to diabetic nephropathy in Japan.
    Sugiyama T; Goryoda S; Inoue K; Sugiyama-Ihana N; Nishi N
    BMC Health Serv Res; 2017 Dec; 17(1):833. PubMed ID: 29246223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data Resource Profile of Shizuoka Kokuho Database (SKDB) Using Integrated Health- and Care-insurance Claims and Health Checkups: The Shizuoka Study.
    Nakatani E; Tabara Y; Sato Y; Tsuchiya A; Miyachi Y
    J Epidemiol; 2022 Aug; 32(8):391-400. PubMed ID: 33518592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the evidence-practice gap to facilitate proper medical care for the elderly: investigation, using databases, of utilization measures for National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB).
    Nakayama T; Imanaka Y; Okuno Y; Kato G; Kuroda T; Goto R; Tanaka S; Tamura H; Fukuhara S; Fukuma S; Muto M; Yanagita M; Yamamoto Y;
    Environ Health Prev Med; 2017 Jun; 22(1):51. PubMed ID: 29165139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical expenses for diabetes care in Japan: Analysis of inter-prefecture differences].
    Kurosaki H; Yoshimura K
    Nihon Koshu Eisei Zasshi; 2020; 67(8):501-508. PubMed ID: 32879236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Routine Nephropathy Monitoring and Subsequent Change in Estimated Glomerular Filtration Rate in Patients With Diabetes Mellitus: A Japanese Non-Elderly Cohort Study.
    Ono S; Ono Y; Koide D; Yasunaga H
    J Epidemiol; 2020 Aug; 30(8):326-331. PubMed ID: 31204363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of diabetes diagnosis in health insurance claims data in Taiwan.
    Lin CC; Lai MS; Syu CY; Chang SC; Tseng FY
    J Formos Med Assoc; 2005 Mar; 104(3):157-63. PubMed ID: 15818428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical expenditures for fragility hip fracture in Japan: a study using the nationwide health insurance claims database.
    Mori T; Komiyama J; Fujii T; Sanuki M; Kume K; Kato G; Mori Y; Ueshima H; Matsui H; Tamiya N; Sugiyama T
    Arch Osteoporos; 2022 Apr; 17(1):61. PubMed ID: 35403938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-efficacy remains a vital factor in reducing the risk of dialysis in type 2 diabetes care.
    Liao K; Lin KC; Chiou SJ
    Medicine (Baltimore); 2021 Jul; 100(28):e26644. PubMed ID: 34260563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of risk models for major adverse chronic renal outcomes among patients with type 2 diabetes mellitus using insurance claims: a retrospective observational study.
    Wysham CH; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Duh MS; Young JB
    Curr Med Res Opin; 2020 Feb; 36(2):219-227. PubMed ID: 31625766
    [No Abstract]   [Full Text] [Related]  

  • 17. The challenge of healthcare big data to China's commercial health insurance industry: evaluation and recommendations.
    Wu J; Qiao J; Nicholas S; Liu Y; Maitland E
    BMC Health Serv Res; 2022 Sep; 22(1):1189. PubMed ID: 36138390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure control in chronic kidney disease according to underlying renal disease: the Fukushima CKD cohort.
    Nakajima A; Tanaka K; Saito H; Iwasaki T; Oda A; Kanno M; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
    Clin Exp Nephrol; 2020 May; 24(5):427-434. PubMed ID: 31875937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipoprotein(a) levels and diabetic nephropathy among Japanese patients with type 2 diabetes mellitus.
    Senba H; Furukawa S; Sakai T; Niiya T; Miyake T; Yamamoto S; Ueda T; Torisu M; Minami H; Miyaoka H; Onji M; Tanaka K; Matsuura B; Tanigawa T; Hiasa Y; Miyake Y
    J Diabetes Complications; 2016 Jul; 30(5):923-7. PubMed ID: 26947887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of diabetic nephropathy in current nephrological practice.
    Locatelli F; Canaud B; Eckardt KU; Stenvinkel P; Wanner C; Zoccali C
    Nephrol Dial Transplant; 2003 Sep; 18(9):1716-25. PubMed ID: 12937216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.